SU122251A1 - Method of making associated vaccine concentrate against emphysematous carbuncle, malignant edema and cattle pasteurellosis - Google Patents

Method of making associated vaccine concentrate against emphysematous carbuncle, malignant edema and cattle pasteurellosis

Info

Publication number
SU122251A1
SU122251A1 SU616146A SU616146A SU122251A1 SU 122251 A1 SU122251 A1 SU 122251A1 SU 616146 A SU616146 A SU 616146A SU 616146 A SU616146 A SU 616146A SU 122251 A1 SU122251 A1 SU 122251A1
Authority
SU
USSR - Soviet Union
Prior art keywords
emphysematous
carbuncle
pasteurellosis
cattle
malignant edema
Prior art date
Application number
SU616146A
Other languages
Russian (ru)
Inventor
Ф.И. Каган
А.И. Колесова
Н.М. Никифорова
Original Assignee
Ф.И. Каган
А.И. Колесова
Н.М. Никифорова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ф.И. Каган, А.И. Колесова, Н.М. Никифорова filed Critical Ф.И. Каган
Priority to SU616146A priority Critical patent/SU122251A1/en
Application granted granted Critical
Publication of SU122251A1 publication Critical patent/SU122251A1/en

Links

Description

Предлагаемый способ позвол ет получать ассоципроваппую концентрат-вакцину дл  иммунизации крупного рогатого скота одновременно против трех заболеваццй, что дает преимущества иеред моновакцинами .The proposed method makes it possible to obtain assotropic vaccine concentrate for immunization of cattle simultaneously against three diseases, which gives advantages to monovaccines.

Способ изготовлени  вакцины заключаетс  в том, что используютс  вирулентные иммуногенные Ц1таммы микробных культур, которые выращивают на бульоне Хоттингера раздельно. Культуры эмфизематозного карбункула, асептичеекого внбриона и 50% пгктереллезной культуры выращивают в течение 24 часов, а другие 50о пастереллсзной культуры-в течение 4 суток. Культуры эмфизематозного карбунк па и синтетического вибриона после выращиванн ; формал низнруют 0,5и формалина и в течение п ти суток выдерживают в термостате, а затем смешивают. К полученной смеси добавл ют 3%-ный раствор гидроокиси алюмини  в количестве 15% к объему вакцнны, эту смесь отстаивают и, с целью концентрации вакцины, две трети прозрачной надосадочной жидкости удал  от. Пастереллезную культуру, сконцентр)1рова П ую таким же способом, только без предварительной обработки формалином, добавл ют к концентрату смеси эмфизематозного карбункула и синтетического вибриона.A method of making a vaccine is to use virulent immunogenic Clar microbial cultures that are grown separately on the Hottinger broth. The cultures of emphysematous carbuncle, aseptic ugrion and 50% of the pgcterelase culture are grown for 24 hours, and the other 50 o of pasteurellosis culture for 4 days. Cultures of emphysematous carbunks and synthetic vibrios after being grown; Formal darken 0.5 and formalin and kept in a thermostat for five days and then mixed. To the resulting mixture was added a 3% aluminum hydroxide solution in an amount of 15% by volume of the vaccine, this mixture was settled and, for the purpose of concentrating the vaccine, two thirds of the clear supernatant was removed. Pasteurellosis culture, concentrate) In the same manner, without pretreatment with formalin, emphysematous carbuncle and synthetic vibrio are added to the concentrate.

Приготовленную тройную смесь став т в термостат на 24-36 часов, после чего расфасовывают. Вакцину провер ют на стерильность высевами на питательные среды. Безвредность и активность вакцины провер етс  на кроликах, морских свинках и голуб х.The prepared ternary mixture is placed in a thermostat for 24-36 hours, after which it is packaged. The vaccine is checked for sterility by plating on nutrient media. The safety and potency of the vaccine is tested on rabbits, guinea pigs and blue.

Изготовленную данным способом вакцину ввод т внутримышечно двукратно по 5 и 10 мл и однократно по 15 мл каждому животному независимо от возраста.The vaccine prepared by this method is administered intramuscularly twice in 5 and 10 ml and once in 15 ml each animal, regardless of age.

Пред м е т и з о б р е т е м и  PREPARATION AND RESULTS

Способ изготовлени  ассоциированной концентрат-вакцины против эмфизематозного карбункула, злокачественного отека и настереллеза крупного рогатого скота, отличающийс  тем, что, с целью получени  активной вакцины, в нем используют вирулентные и иммуногенные штаммы возбудителей указанных заболеваний, которые выращивают раздельно, в разные сроки на бульоне Хоттингера, при этом первые два щтамАШ перед смешиванием обрабатывают формалином, затем раствором гидроокиси аллюмини , а после концентрации смешивают с пастереллезной концентрированной культурой, не подвергавшейс  обработке формалином и став т в термостат полученную тройную смесь на 24- 36 час, после чего вакцину расфасовывают.A method of manufacturing an associated vaccine concentrate against emphysematous carbuncle, malignant edema, and cattle overgrowth, characterized in that it uses virulent and immunogenic strains of pathogens of these diseases, which are grown separately, at different times on Hottinger broth , while the first two tablets are mixed with formalin before mixing, then with aluminum hydroxide solution, and after the concentration is mixed with a pasteurelleic concentrate Anna culture not treated with formalin and podvergavsheys becoming into thermostat resulting ternary mixture on a 24- 36 hour, after which a vaccine is packaged.

SU616146A 1959-01-08 1959-01-08 Method of making associated vaccine concentrate against emphysematous carbuncle, malignant edema and cattle pasteurellosis SU122251A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU616146A SU122251A1 (en) 1959-01-08 1959-01-08 Method of making associated vaccine concentrate against emphysematous carbuncle, malignant edema and cattle pasteurellosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU616146A SU122251A1 (en) 1959-01-08 1959-01-08 Method of making associated vaccine concentrate against emphysematous carbuncle, malignant edema and cattle pasteurellosis

Publications (1)

Publication Number Publication Date
SU122251A1 true SU122251A1 (en) 1959-11-30

Family

ID=48393959

Family Applications (1)

Application Number Title Priority Date Filing Date
SU616146A SU122251A1 (en) 1959-01-08 1959-01-08 Method of making associated vaccine concentrate against emphysematous carbuncle, malignant edema and cattle pasteurellosis

Country Status (1)

Country Link
SU (1) SU122251A1 (en)

Similar Documents

Publication Publication Date Title
Fishman Antibody formation in vitro
Borsos et al. Antigenic relationship between Mycobacterium bovis (BCG) and a guinea pig hepatoma
Smih et al. Immunological responses of young animals. II. Antibody production in calves.
SU122251A1 (en) Method of making associated vaccine concentrate against emphysematous carbuncle, malignant edema and cattle pasteurellosis
Welshimer Staphylococcal antibody production in response to injections with Listeria monocytogenes
GB1549345A (en) Gonococcal pili processes for the preparation thereof and the use thereof
York et al. Isolation and identification of infectious bovine rhinotracheitis virus in tissue culture
Lieberman et al. Ascites induced in mice by staphylococcus
KIMURA et al. Serological diagnosis of bacterial kidney disease of salmonid (BKD): immunodiffusion test by heat stable antigen extracted from infected kidney
Welt Urinary excretion of trichina antigen in experimental trichinosis.
Baer et al. The immunology and chemistry of tuberculin: I. The isolation of dialyzable and nondialyzable tuberculin-active components from unheated BCG culture filtrates
SU127365A1 (en) Deep method of making pasteurellosis vaccine in cattle, sheep and pigs in a tanker
Richardson et al. Prenatal immunization of the lamb to Brucella secondary antibody response in utero and at birth
Brem et al. L forms of Listeria monocytogenes: I. In Vitro Induction and Propagation of L forms in All Serotypes
Hwon The production of diphtheric antitoxin in tissue-cultures
SU103907A1 (en) Method for producing polyvalent toxoid for immunization against anaerobic infections
GB1276218A (en) Calf diarrhea virus vaccine and processes
Svec Bovine intracutaneous and serological reactions to fractions of Trichomonas foetus (Protozoon)
Zinsser et al. Further Studies of Agar-slant Tissue Cultures of Typhus Rickettsiæ.
CN106749651B (en) Preparation method of streptococcus agalactiae type specific antiserum
JPS5920226A (en) Veterinary vaccine and preparation thereof
Nagy Induction of autohemolysin formation in spleen cell culture by “immunogenic RNA”
Wong et al. Polysaccharides of C. diphtheriœ.
RU2092187C1 (en) Inactivated vaccine for salmonellosis control in sheep
SU134392A1 (en) The method of obtaining antipasterelae serum